A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy
Conditions: Non Small Cell Lung Cancer; Brain Metastases Interventions: Drug: Icotinib; Radiation: SRS/WBRT/HA-WBRT/SMART Sponsor: Betta Pharmaceuticals Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Neurology | Non-Small Cell Lung Cancer | Radiation Therapy | Research | Study